Exelixis | EXEL - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Akebia Therapeutics 167 37 2023-12
Amgen 28K 1.3K 2024-12
AstraZeneca USD 89.9K 6.4K 2023-12
Bayer 99.72K 1.65K 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Cytokinetics 498 75 2024-12
Eisai 13.51K 2.44K 2025-12
Eli Lilly 47K 4K 2024-12
Exelixis 1.15K 163 2025-12
Genmab 2.68K 478 2024-12
Glaxosmithkline GBP 69.4K 20.7K 2022-12
Incyte 2.62K 93 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
MacroGenics 339 18 2023-12
Merck 75K 3K 2024-12
Moderna 5.8K 200 2024-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
Puma Biotechnology 185 7 2023-12
Sanofi EUR 91.57K 3.87K 2022-12
Takeda 47.46K 1.83K 2025-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Xencor 250 30 2024-12